Recent success in gastric bypass surgery is forcing surgeons to make tough decisions about who should go under the knife and who shouldn’t. The success stories also stoking debate about its use as a treatment for type 2 diabetes. Mounting evidence suggests this type of surgery may dramatically improve patients with the disease, freeing them from a lifetime of diabetes medications.
Still, more long-term studies are needed, and clinicians and policymakers must reach a consensus on who should have access to this type of surgery, notedRubino, who directed the 1st World Congress on Interventional Therapies for Type 2 Diabetes, held in New York City in September.
About the surgery:
An estimated 205,000 bariatric surgeries were performed in the United States in 2007, according to the American Society for Metabolic & Bariatric Surgery (ASMBS). That’s an increase of almost 20 percent from two years earlier.One study, led by Ted Adams of the University of Utah School of Medicine, tracked almost 16,000 obese people, half of whom had weight-loss surgery. After an average of seven years, the death rate was 40 percent lower for people who had the surgery compared with those who didn’t. Diabetes-related deaths were cut by a whopping 92 percent.
Source: US News